RBNW just fine Market cap $1,3 million dollar If it’s $400 million market cap and without revenue I will say I am maybe investing into something at the highest risk but investing into a shell been taking over by powerful lady who used to be ceo of successful company went from 0.4 to $45 and market cap of $4 billion And have excellent revenue And owned ?? of the preferred shares and voting shares This is the lowest risk ever you will invest in Regarding Huss and the past of the company it have nothing to do for the future merger and the new business in this play I don’t want to waste my time on that because it’s not there and soon Huss won’t be even in this one anymore
Advice to you when you buy biotech don’t buy something like $300 to $400 million market cap there is not much room to make Specially if there is lots room for issuing shares and in the otc Buy them in big Nasdaq and when they are only 14 to 25 million market cap There is 100 of them out there with big potential